Vascular permeabilization by intravenous arachidonate in the rat peritoneal cavity: Antagonism by antioxidants

European Journal of Pharmacology

Volumn 466, Issue 1-2, 2003, Pages 199-205

  Alvarez Guerra, Miriam ^a   Hannaert, Patrick ^a   Hider, Hamida ^a   Chiavaroli, Carlo ^b   Garay, Ricardo P ^a  

^a INSERM   (France)

^b Vifor (International) Inc   (Switzerland)

Author keywords

Antioxidant; Arachidonate; Capillary permeability; Reactive oxygen species

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; ASCORBIC ACID; FLAVANOID; PROSTACYCLIN; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; TROXERUTIN; CARRAGEENAN; ETAMSYLATE; HYDROXYL RADICAL; MANNITOL; NITRIC OXIDE; RADICAL; SEROTONIN; SUPEROXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EVALUATION; IN VIVO STUDY; MALE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT; REDUCTION; DRUG DETERMINATION; FENTON REACTION; HEMOSTASIS; IN VITRO STUDY; PAW EDEMA;

EID: 0037432596     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01544-9     Document Type: Article

References (39)

1. Balsa D., Merlos M., Giral M., Ferrando R., Garcia-Rafanell J., Forn J. Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediators. J. Lipid Mediators Cell Signalling. 17:1997;31-45.
2. Beck R., Bertolino S., Abbot S.E., Aaronson P.I., Smirnov S.V. Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circ. Res. 83:1998;923-931.
3. Becker P.M., Sanders S.P., Price P., Christman B.W. F2-isoprostane generation in isolated ferret lungs after oxidant injury or ventilated ischemia. Free Radical Biol. Med. 25:1998;703-711.
4. Bertolino F., Valentin J.P., Maffre M., Bessac A.M., John G.W. TxA2 receptor activation elicits organ-specific increases in microvascular permeability in the rat. Am. J. Physiol. 268:1995;R366-R374.
5. Brunet J., Farine J.C., Garay R.P., Hannaert P. Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat. Eur. J. Pharmacol. 358:1998;213-220.
6. Burba J.V., Becking G.C. Effect of the antioxidant nordihydroguaiaretic acid on the in vitro activity of catechol-o-methyl transferase. Arch. Int. Pharmacodyn. Ther. 180:1969;323-330.
7. Caccese D., Pratico D., Ghiselli A., Natoli S., Pignatelli P., Sanguigni V., Iuliano L., Violi F. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation-role of arachidonic acid metabolism. Thromb. Haemostasis. 83:2000;485-490.
8. Chacur M., Picolo G., Gutierrez J.M., Teixeira C.F., Cury Y. Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom. Toxicon. 39:2001;1173-1181.
9. Chemtob S., Roy M.S., Abran D., Fernandez H., Varma D.R. Prevention of postasphyxial increase in lipid peroxides and retinal function deterioration in the newborn pig by inhibition of cyclooxygenase activity and free radical generation. Pediatr. Res. 33:1993;336-340.
10. Cirino G. Multiple controls in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase. Biochem. Pharmacol. 55:1998;105-111.
11. Dana R., Leto T.L., Malech H.L., Levy R. Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase. J. Biol. Chem. 273:1998;441-445.
12. Daniels I., Lindsay M.A., Keany C.I., Burden R.P., Fletcher J., Haynes A.P. Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent. Clin. Diagn. Lab. Immunol. 5:1998;683-689.
13. De Araujo A.L., De Souza A.O., Da Cruz-Hofling M.A., Flores C.A., Bon C. Bothrops lanceolatus (Fer de lance) venom induces oedema formation and increases vascular permeability in the mouse hind paw. Toxicon. 38:2000;209-221.
14. De Lima W.T., Sirois P., Jancar S. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions. Eur. J. Pharmacol. 213:1992;63-70.
15. De Matos I.M., Rocha O.A., Leite R., Freire O., Maia L. Lung oedema induced by Tityus serrulatus scorpion venom in the rat. Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol. Endocrinol. 118:1997;143-148.
16. Easton A.S., Fraser P.A. Arachidonic acid increases cerebral microvascular permeability by free radicals in single pial microvessels of the anaesthetized rat. J. Physiol. 507:1998;541-547.
17. Farmer P.J., Bernier S.G., Lepage A., Guillemette G., Regoli D., Sirois P. Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins. Am. J. Physiol. 280:2001;L732-L738.
18. Gute D.C., Ishida T., Yarimizu K., Korthuis R.J. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol. Cell. Biochem. 179:1998;169-187.
19. Hope W.C., Welton A.F., Fiedler O., Nagy C., Batula O., Bernardo C., Coffey J.W. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem. Pharmacol. 32:1983;367-371.
20. Irie K., Fujii E., Ishida H., Wada K., Suganuma T., Nishikori T., Yoshioka T., Muraki T. Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin. Br. J. Pharmacol. 133:2001;237-242.
21. Ivey C.L., Stephenson A.H., Townsley M.I. Involvement of cytochrome P-450 enzyme activity in the control of microvascular permeability in canine lung. Am. J. Physiol. 275:1998;L756-L763.
22. Kubes P.J., Gaboury P. Rapid mast cell activation causes leukocyte-dependent and -independent permeability alterations. Am. J. Physiol. 271:1996;H2438-H2446.
23. Lloret S., Moreno J.J. Effects of an antinflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol application. Biochem. Pharmacol. 50:1995;347-353.
24. Lugrin D., Chave S., Raucoules M., Grimaud D.U. Transvascular fluid exchange disturbed by capillary injuries. Ann. Fr. Anesth. Reanim. 15:1996;436-446.
25. 2 on arachidonic acid release induced by reactive oxygen species. Arch. Biochem. Biophys. 392:2001;257-262.
26. Morrow J.D., Minton T.A., Badr K.F., Roberts L.J. II Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. Biochim. Biophys. Acta. 1210:1994;244-248.
27. Okiji T., Morita I., Sunada I., Murota S. Involvement of arachidonic acid metabolites in increases in vascular permeability in experimental dental pulpal inflammation in the rat. Arch. Oral Biol. 34:1989;523-528.
28. Rao T.S., Currie J.L., Shaffer A.F., Isakson C. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation. 17:1993;723-741.
29. Robison T.W., Sevanian A., Forman H.J. Inhibition of arachidonic acid release by nordihydroguaiaretic acid and its antioxidant action in rat alveolar macrophages and Chinese hamster lung fibroblasts. Toxicol. Appl. Pharmacol. 105:1990;113-122.
30. Roshchupkin D.I., Murina M.A. Free-radical and cyclooxygenase-catalyzed lipid peroxidation in membranes of blood cells under UV irradiation. Membr. Cell. Biol. 12:1998;279-286.
31. Salari H., Braquet P., Borgeat P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins, Leukotrienes Med. 13:1984;53-60.
32. Samuelsson B. Arachidonic acid metabolism: role in inflammation. Z. Rheumatol. 50(Suppl. 1):1991;3-6.
33. Seeger W., Menger M., Walmrath D., Becker G., Grimminger F., Neuhof H. Arachidonic acid lipoxygenase pathways and increased vascular permeability in isolated rabbit lungs. Am. Rev. Respir. Dis. 136:1987;964-972.
34. Shi F., Cavitt J., Audus K.L. 21-Aminosteroid and 2-(aminomethyl)chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radical Biol. Med. 19:1995;349-357.
35. Stenson W.F., Chang K., Williamson J.R. Tissue differences in vascular permeability induced by leukotriene B4 and prostaglandin E2 in the rat. Prostaglandins. 32:1986;5-17.
36. Unterberg A., Wahl M., Hammersen F., Baethmann A. Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid. Acta Neuropathol. (Berlin). 73:1987;209-219.
37. Wang M.M., Reynaud D., Pace-Asciak C.R. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability. Biochim. Biophys. Acta. 1436:1999;354-362.
38. 2, and the subsequent release of arachidonic acid, in signalling by rac for the generation of intracellular reactive oxygen species in rat-2 fibroblasts. Biochem. J. 348:2000;525-530.
39. Xing M., Tao L., Insel P.A. Role of extracellular signal-regulated kinase and PKC alpha in cytosolic PLA2 activation by bradykinin in MDCK-D1 cells. Am. J. Physiol. 272:1997;C1380-C1387.